52 results
424B5
BTAI
BioXcel Therapeutics Inc
25 Mar 24
Prospectus supplement for primary offering
4:01pm
specified by an applicable income tax treaty) on gain realized upon the sale or other taxable disposition of the Securities, which may be offset by certain
424B5
vw1lovin5mj 37lp41al
8 Feb 24
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
od2ydwa2
10 Mar 22
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights
8:12am
8-K
EX-99.1
d3e1zk6
10 Nov 21
BioXcel Therapeutics Reports Third Quarter 2021 Financial Results and Recent Operational Highlights
7:15am